Aethlon Medical Files 8-K
Ticker: AEMD · Form: 8-K · Filed: Nov 12, 2024 · CIK: 882291
| Field | Detail |
|---|---|
| Company | Aethlon Medical Inc (AEMD) |
| Form Type | 8-K |
| Filed Date | Nov 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, reporting, medical-devices
TL;DR
AETH filed an 8-K, looks like standard reporting, no major news.
AI Summary
Aethlon Medical, Inc. filed an 8-K on November 11, 2024, reporting other events and financial statements. The company, incorporated in Nevada, is headquartered in San Diego, California, and operates in the surgical and medical instruments sector. This filing does not appear to contain specific financial transaction details or significant operational updates beyond routine reporting requirements.
Why It Matters
This 8-K filing indicates routine corporate reporting by Aethlon Medical, Inc. It does not appear to contain material new information that would immediately impact the company's stock or operations.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not disclose any new material events, risks, or significant financial changes.
Key Numbers
- 001-37487 — SEC File Number (Identifies the company's filing with the SEC.)
- 13-3632859 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- AETHLON MEDICAL INC (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- San Diego, California (location) — Principal executive offices
- 3841 (sic_code) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of November 11, 2024.
When was Aethlon Medical, Inc. incorporated?
Aethlon Medical, Inc. was incorporated in Nevada.
What is Aethlon Medical, Inc.'s principal executive office address?
The principal executive offices are located at 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121.
What is the Standard Industrial Classification (SIC) code for Aethlon Medical, Inc.?
The SIC code is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.
Does this filing indicate any recent name changes for the company?
The filing mentions a former company name, 'BISHOP EQUITIES INC', with a date of name change as '19930602', indicating a past name change.
Filing Stats: 458 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-11-12 09:00:08
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share AEMD The Nasdaq
Filing Documents
- aethlon_8k.htm (8-K) — 25KB
- aethlon_ex9901.htm (EX-99.1) — 13KB
- image_001.jpg (GRAPHIC) — 15KB
- 0001683168-24-007858.txt ( ) — 236KB
- aemd-20241111.xsd (EX-101.SCH) — 3KB
- aemd-20241111_lab.xml (EX-101.LAB) — 33KB
- aemd-20241111_pre.xml (EX-101.PRE) — 24KB
- aethlon_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On November 11, 2024, Aethlon Medical, Inc. (the "Company") issued a press release announcing enrollment of the first patient in its Australian safety, feasibility and dose-finding clinical trial for the Company's Hemopurifier in patients with solid tumors not responding to anti-PD-1 antibodies. A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.
01 Financial Statements
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated November 11, 2024. 104 Cover Page Interactive Data File (embedded within the inline XBRL Document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 12, 2024 Aethlon Medical, Inc. By: /s/ James B. Frakes Name: James B. Frakes Interim Chief Executive Officer and Chief Financial Officer 3